HCPCS code C9098 — Ciltacabtagene car pos t.
Status: Deleted.
Effective Oct 1, 2022.
Source: CMS HCPCS Level II.
C9098
DeletedCiltacabtagene car pos t
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code C9098 has been deleted from the HCPCS Level II set.
Termination date: Sep 30, 2022. Claims with a date of service on or after this day will be denied under this code.
No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.
Category:
Outpatient PPS
Section:
C-codes: Outpatient PPS
Effective:
Oct 1, 2022
Terminated:
Sep 30, 2022
Code type:
alphanumeric
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.